GlassScriptPhysician profile
Joseph Basilone
NPI 1518995588
$1,447.75
in general payments reported to CMS, 2019-2025
13 companies · $40.12 in 2025
The $40.12 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $482 · 2021: $517 · 2022: $125 · 2025: $40.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $150.00 | 2021 | |
| Abbott Laboratories | $126.78 | 2020 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2022 | |
| Amgen INC. | $124.99 | 2020 | |
| Abbvie INC. | $124.98 | 2021 | |
| Eisai INC. | $121.60 | 2021 | |
| Allergan, INC. | $120.62 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.00 | 2021 | |
| Novo Nordisk INC | $110.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $99.44 | 2019 | |
| Genentech USA, INC. | $95.80 | 2019 | |
| Medtronic USA, INC. | $88.42 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.12 | 2025 | Hyqvia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Basilone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.